Profile
Henrich R.
K.
Guntermann worked as a Director and President-Europe & Immunology Group at Nuvo Pharmaceuticals, Inc. from 2011 to 2016.
He also worked as a Director at Crescita Therapeutics, Inc. in 2016.
Guntermann holds a doctorate degree from Philipps University of Marburg.
Former positions of Henrich R. K. Guntermann
Companies | Position | End |
---|---|---|
CRESCITA THERAPEUTICS INC. | Director/Board Member | 28/09/2016 |
NUVO PHARMACEUTICALS INC. | President | 15/12/2009 |
Training of Henrich R. K. Guntermann
Philipps University of Marburg | Doctorate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
CRESCITA THERAPEUTICS INC. | Health Technology |
Private companies | 1 |
---|---|
Nuvo Pharmaceuticals, Inc.
Nuvo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Nuvo Pharmaceuticals, Inc. is a pharmaceutical company, which is engaged in developing innovative therapeutic pharmaceutical products. It operates through the following segments: Commercial Business, Production and Service Business, and Licensing and Royalty Business. The Commercial Business segment includes Blexten, Cambia, the canadian business for Resultz and Suvexx, and mature assets. The Production and Service Business segment supplies Pennsaid to Horizon for the U.S. market and is engaged in ongoing partnering efforts for Pennsaid. The Licensing and Royalty Business segment engages in the selling of Vimovo. The company was founded on August 22, 1983 and is headquartered in Mississauga, Canada. | Health Technology |
- Stock Market
- Insiders
- Henrich R. K. Guntermann